(NP (NP (NN Role)) (PP (IN for) (NP (DT the) (JJ Epstein-Barr) (NN virus) (JJ nuclear) (NN antigen) (CD 2))) (PP (IN in) (NP (NP (JJ viral) (NN promoter) (VBG switching)) (PP-TMP (IN during) (NP (NP (JJ initial) (NNS stages)) (PP (IN of) (NP (NN infection))))))) (. .))
(S (PP-TMP (IN During) (NP (NP (JJ latent) (NP (NP (JJ Epstein-Barr) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN EBV)) (-RRB- -RRB-))) (NN infection)) (PP (IN of) (NP (JJ human) (NN B) (NNS lymphocytes))))) (, ,) (NP-SBJ-52 (NP (CD six) (JJ viral) (JJ nuclear) (NN antigen)) (PRN (-LRB- -LRB-) (NP (NNS EBNAs)) (-RRB- -RRB-))) (VP (VBP are) (VP (VBN expressed) (NP (-NONE- *-52)) (PP (IN from) (NP (JJ long) (JJ primary) (NNS transcripts))) (PP (IN by) (NNS means) (IN of) (NP-COOD (NP (JJ alternative) (NN splicing)) (CC and) (NP (JJ alternative) (NN polyadenylylation) (NNS sites)))))) (. .))
(S (NP-SBJ (DT These) (NNS transcripts)) (VP (VBP initiate) (PP (IN from) (NP (NP (CD one)) (PP (IN of) (NP (NP (NP (CD two) (NNS promoters)) (, ,) (NP-COOD (NP (NN Cp)) (CC or) (NP (NN Wp))) (, ,)) (SBAR (WHNP-53 (WDT that)) (S (NP-SBJ (-NONE- *T*-53)) (VP (VBP function) (PP (IN in) (NP (DT a) (ADJP (RB mutually) (JJ exclusive)) (NN fashion))))))))))) (. .))
(S (NP-SBJ-54 (NN Wp)) (VP (VBZ is) (ADVP (RB exclusively)) (VP (VBN utilized) (NP (-NONE- *-54)) (PP-TMP (IN during) (NP (NP (DT the) (JJ initial) (NNS stages)) (PP (IN of) (NP (NP (NN infection)) (PP (IN of) (NP (JJ primary) (NN B) (NNS lymphocytes))))))) (, ,) (S (NP-SBJ-200 (-NONE- *)) (VP (VBN followed) (NP (-NONE- *-200)) (PP (IN by) (NP-LGS (NP (DT a) (NN switch)) (PP (TO to) (NP (NN Cp) (NN usage))))))))) (. .))
(S (NP-SBJ-55 (DT These) (NNS studies)) (VP (VBP have) (VP (VBN been) (VP (VBN extended) (S (NP-SBJ (-NONE- *-55)) (VP (TO to) (VP (VB show) (SBAR (IN that) (S-COOD (S (LST (-LRB- -LRB-) (LS i) (-RRB- -RRB-)) (NP-SBJ-56 (NP (DT a) (JJ mutant) (NN EBV) (NN strain)) (VP (VBG lacking) (NP (NP (DT the) (NN gene)) (VP (VBG encoding) (NP (NN EBNA) (CD 2)))))) (VP (VBZ fails) (S (NP-SBJ (-NONE- *-56)) (VP (TO to) (VP (VB switch) (PP (PP (IN from) (NP (NN Wp) (NP (-NONE- *RNR*-201)))) (PP (TO to) (NP (NN Cp) (NP (-NONE- *RNR*-201)))) (NP-201 (NN usage))) (PP (IN in) (NP (JJ primary) (NN B) (NNS lymphocytes))) (, ,) (SBAR (IN although) (S (NP-SBJ (DT the) (NN virus)) (VP (VBZ contains) (NP (DT a) (JJ functional) (NN Cp)))))))))) (: ;) (S (LST (-LRB- -LRB-) (LS ii) (-RRB- -RRB-)) (NP-SBJ (NP (DT a) (NN region)) (NP (QP (IN from) (CD -429) (TO to) (CD -245)) (NN base) (NNS pairs)) (ADJP (JJ upstream) (PP (IN of) (NP (NN Cp))))) (VP (VBZ is) (ADJP-PRD (JJ essential) (PP (IN for) (NP (NP (NN Cp) (NN activity)) (PP (IN in) (NP (NN B) (NNS lymphocytes))))) (, ,) (CC but) (PP (RB only) (IN in) (NP (NP (DT the) (NN context)) (PP (IN of) (NP (ADJP-COOD (ADJP (JJ upstream)) (CC and) (ADJP (JJ downstream))) (NNS sequences)))))))) (: ;) (S (LST (-LRB- -LRB-) (LS iii) (-RRB- -RRB-)) (NP-SBJ (DT this) (NN region)) (VP (VBZ contains) (NP (DT an) (NN EBNA) (JJ 2-dependent) (NN enhancer)))) (: ;) (CC and) (S (LST (-LRB- -LRB-) (LS iv) (-RRB- -RRB-)) (NP-SBJ (NP (NN DNase) (CD I) (NN protection)) (VP (VBG employing) (NP (NP (JJ nuclear) (NNS extracts)) (PP (IN from) (NP (NP-COOD (NP (NN B)) (CC and) (NP (NN T))) (NNS lymphocytes)))))) (VP (VBD revealed) (NP (NP (DT a) (JJ B-cell-specific) (NN footprint)) (PP (IN in) (NP (NP (DT the) (NN region)) (PP (IN of) (NP (DT the) (ADJP (NN EBNA) (JJ 2-dependent)) (NN enhancer)))))))))))))))) (. .))
(S (NP-SBJ (DT These) (NNS results)) (VP (VBP support) (NP (NP (DT a) (NN model)) (PP (IN for) (NP (NP (JJ viral) (NN promoter) (NN switching)) (PP-TMP (IN during) (NP (NP (DT the) (JJ initial) (NNS stages)) (PP (IN of) (NP (NN infection)))) (SBAR (WHPP-57 (IN in) (WHNP (WDT which))) (S (NP-SBJ (NN Wp) (NN activity)) (VP (VBZ leads) (PP (TO to) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN EBNA) (CD 2))))) (PP (-NONE- *T*-57)) (, ,) (S-ADV (NP-SBJ-202 (-NONE- *)) (VP (VBN followed) (NP (-NONE- *-202)) (PP (IN by) (NP-LGS (NP (NP (NN activation)) (PP (IN of) (NP (NN Cp)))) (PP (IN through) (NP (DT the) (ADJP (NN EBNA) (JJ 2-dependent)) (NN enhancer))))))))))))))) (. .))
